Alpana Singh1, Nusrat Jahan2, Gita Radhakrishnan3, B D Banerjee4. 1. Assistant Professor, Department of Obstetrics and Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital , Delhi, India . 2. Senior Resident, Department of Obstetrics and Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital , Delhi, India . 3. Director Professor and Head, Department of Obstetrics and Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital , Delhi, India . 4. Professor, Department of Biochemistry, University College of Medical Sciences and Guru Teg Bahadur Hospital , Delhi, India .
Abstract
INTRODUCTION: Infertility is defined as inability to conceive after 1 year of unprotected intercourse and it affects 7% of male population and 8-10% of couples. According to estimates WHO, 13-19 million couples in India are infertile. Oxidative stress is the causative factor in 25% of infertile males. AIM: To study the efficacy of antioxidant therapy on oxidative stress parameters in seminal plasma of infertile male. MATERIALS AND METHODS: Forty patients of male infertility were enrolled in study after two abnormal semen analyses reports at 2-3 weeks interval, of oligozoospermia and/or asthenozoospermia, as per WHO guide line 1999. First semen sample was collected at a time of enrollment of study and second semen sample was collected three months after combined antioxidant therapy. Semen samples from the infertile male (the second confirmatory sample of oligoasthenozoospermia) were taken and after liquefaction semen sample were utilized for various analyses, 0.5 ml of sample for standard semen analysis, 1.2 ml sample for separation of seminal plasma to evaluate Oxidative stress (OS) parameters like Malondialdehyde (MDA), Protein Carbonyl (PC) and antioxidant capacity by Glutathione (GSH). We followed the patient for three months after completion of the treatment. RESULTS: Semen parameters - Out of 40 patients recruited in the study group 7 patients had only oligospermia (1 to 20 million/ml) and 31 patients had oligoasthenozoospermia (motility range 0-50%) and 2 patients had oligoasthenoteratozoospermia. There was no patient with asthenospermia alone as abnormal semen parameters. After the three months treatment with combined antioxidants the semen parameters like count (mean SD = -1.70±1.44) and motility (mean +SD= -9.56±9.05) were significantly increased (p-value=0.000). Oxidative Stress Assessment - The level of MDA which is a marker of oxidative stress was significantly lower after the three months therapy of antioxidants (p-value=0.002) whereas another marker which is denoted by PC was also lower after the treatment but not statistically significant (p-value=0.584). The level of antioxidants GSH also significantly increased after the treatment (p-value=0.000). After the treatment out of 40, five patients conceived (16.7%). CONCLUSION: As we have seen through this study antioxidant dramatically reduced the oxidative stress markers and enhancing the antioxidant enzymes. They should be used on routine basis in case of male infertility.
INTRODUCTION: Infertility is defined as inability to conceive after 1 year of unprotected intercourse and it affects 7% of male population and 8-10% of couples. According to estimates WHO, 13-19 million couples in India are infertile. Oxidative stress is the causative factor in 25% of infertile males. AIM: To study the efficacy of antioxidant therapy on oxidative stress parameters in seminal plasma of infertile male. MATERIALS AND METHODS: Forty patients of male infertility were enrolled in study after two abnormal semen analyses reports at 2-3 weeks interval, of oligozoospermia and/or asthenozoospermia, as per WHO guide line 1999. First semen sample was collected at a time of enrollment of study and second semen sample was collected three months after combined antioxidant therapy. Semen samples from the infertile male (the second confirmatory sample of oligoasthenozoospermia) were taken and after liquefaction semen sample were utilized for various analyses, 0.5 ml of sample for standard semen analysis, 1.2 ml sample for separation of seminal plasma to evaluate Oxidative stress (OS) parameters like Malondialdehyde (MDA), Protein Carbonyl (PC) and antioxidant capacity by Glutathione (GSH). We followed the patient for three months after completion of the treatment. RESULTS: Semen parameters - Out of 40 patients recruited in the study group 7 patients had only oligospermia (1 to 20 million/ml) and 31 patients had oligoasthenozoospermia (motility range 0-50%) and 2 patients had oligoasthenoteratozoospermia. There was no patient with asthenospermia alone as abnormal semen parameters. After the three months treatment with combined antioxidants the semen parameters like count (mean SD = -1.70±1.44) and motility (mean +SD= -9.56±9.05) were significantly increased (p-value=0.000). Oxidative Stress Assessment - The level of MDA which is a marker of oxidative stress was significantly lower after the three months therapy of antioxidants (p-value=0.002) whereas another marker which is denoted by PC was also lower after the treatment but not statistically significant (p-value=0.584). The level of antioxidants GSH also significantly increased after the treatment (p-value=0.000). After the treatment out of 40, five patients conceived (16.7%). CONCLUSION: As we have seen through this study antioxidant dramatically reduced the oxidative stress markers and enhancing the antioxidant enzymes. They should be used on routine basis in case of male infertility.
Entities:
Keywords:
Manoldialdihyde; Protein Carbonyl; Reactive oxygen species
Authors: Ira D Sharlip; Jonathan P Jarow; Arnold M Belker; Larry I Lipshultz; Mark Sigman; Anthony J Thomas; Peter N Schlegel; Stuart S Howards; Ajay Nehra; Marian D Damewood; James W Overstreet; Richard Sadovsky Journal: Fertil Steril Date: 2002-05 Impact factor: 7.329
Authors: Malik Adewoyin; Muhammad Ibrahim; Ramli Roszaman; Muhammad Lokman Md Isa; Nur Aizura Mat Alewi; Ainin Azwani Abdul Rafa; Mohd Nur Nasyriq Anuar Journal: Diseases Date: 2017-03-01
Authors: Kazim Sahin; Mehmet Tuzcu; Cemal Orhan; Hasan Gencoglu; Nurhan Sahin; Fatih Akdemir; Gaffari Turk; Ismet Yilmaz; Vijaya Juturu Journal: Evid Based Complement Alternat Med Date: 2018-04-29 Impact factor: 2.629
Authors: Ashok Agarwal; Kristian Leisegang; Ahmad Majzoub; Ralf Henkel; Renata Finelli; Manesh Kumar Panner Selvam; Nicholas Tadros; Neel Parekh; Edmund Y Ko; Chak Lam Cho; Mohamed Arafa; Marco G Alves; Pedro Fontes Oliveira; Juan G Alvarez; Rupin Shah Journal: World J Mens Health Date: 2021-01-15 Impact factor: 5.400